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How do CFTR mutations cause cystic fibrosis?
The key defect in cystic fibrosis is loss of chloride conductance, but
mutations of the cystic fibrosis gene product, the CFTR, have multiple
effects on cell physiology; new results help to reconcile these facts.
Two major discoveries have transformed our under-
standing of cystic fibrosis, a genetic disease in which
thick secretions accumulate in airways, digestive organs
and sperm duct. The first was that cystic fibrosis involves
a basic defect in epithelial ion transport [1], which is
manifested primarily as the loss of chloride conductance
[2]. The connection between the loss of epithelial
chloride conductance and many of the symptoms of
cystic fibrosis is explained by a well-established model in
which fluid secretion is driven by chloride secretion, the
last step of which occurs through a chloride channel [3].
Loss of conductance through the chloride channel
reduces fluid secretion, leading to airway obstruction by
condensed macromolecules; salt absorption is also com-
promised in some tissues. The other great advance was
the cloning of the cystic fibrosis gene [4], which brought
the enormous power of molecular biology to cystic
fibrosis researchers. This led to the demonstration that
the cystic fibrosis gene product is a chloride channel [5],
validating earlier electrophysiological analyses and leading
to the hypothesis that the fundamental physiological
defect in cystic fibrosis is loss of the chloride conductance
mediated by the cystic fibrosis gene product (Fig. 1).
Two major challenges to the chloride channel hypothesis
remain. One arises from the structure of the cystic fibro-
sis gene product, named 'CFTR' for cystic fibrosis trans-
membrane conductance regulator. The CFTR contains
two nucleotide-binding domains and is a member of the
family of ATP-hydrolyzing transporter proteins that
includes P-glycoprotein, which confers multidrug resis-
tance on cells in which it is expressed, and STE6, which
transports a polypeptide pheromone out of yeast cells.
These similarities in structure suggested that CFTR might
transport something involved in regulating chloride con-
ductance. Indeed, CFTR was named in such a way as to
include this possibility. When CFTR was shown to have
intrinsic channel activity, this line of reasoning abated
briefly, but it re-emerged with the claim that P-glycopro-
tein is both a transporter and a swelling-activated chloride
channel [6]. The subsequent rejection of that hypothesis
[7] has not dimmed enthusiasm for the basic idea, which
can be restated for CFTR as follows: if CFTR is just a
channel, why does it have such a complex structure?
A second challenge to the view that CFTR is simply a
chloride channel arises from the pleiotropic consequen-
ces of CFTR mutations. Researchers - myself included
- who would like to derive the pathophysiology of cys-
tic fibrosis from decreased chloride conductance have
been hard put to account for the pleiotropic effects of
CFTR mutations. These include alterations in sodium
conductance, in chloride conductance mediated by non-
CFTR channels, in pH regulation and in properties of
cell-surface glycoproteins. How does CFTR influence
these varied cellular properties and, more importantly,
what contributions do these alterations make to the
pathology of cystic fibrosis? Several recent papers bring
new prominence to these challenges to the chloride
channel hypothesis.
Fig. 1. How does loss of CFTR cause cystic fibrosis? The diagram
shows known and suggested activities of CFTR. The only unchal-
lenged function of the CFTR is as a chloride channel (1), which
in some epithelia is essential for fluid secretion or salt absorption.
The CFTR may transport ATP and bicarbonate ions (2), but this
not been observed in all laboratories. The transport of other mol-
ecules (3) is speculative at present, as is the suggestion that CFTR
can affect other membrane molecules, perhaps by direct pro-
tein-protein interactions (4). Each of these pathways could trigger
complex downstream events; for example, evidence discussed in
the text suggests that ATP is exported from the cell by the CFTR
and activates external receptors which in turn activate other
chloride channels.
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CFTR and epithelial sodium channels
When an increased voltage across the nasal epithelium of
cystic fibrosis subjects was discovered, it was attributed to
increased sodium transport [1]. Quinton [2] subsequently
proposed the alternative hypothesis that the increased
voltage is the result of decreased chloride conductance.
After numerous studies, most researchers were convinced
that decreased chloride conductance is the fundamental
problem in cystic fibrosis, but that both decreased chlor-
ide conductance and increased sodium conductance
occur, at least in cystic fibrosis airway tissues.
Any remaining skepticism about the latter conclusion
should be dispelled by a new study [8] in which the
recently cloned epithelial sodium channel was expressed
in epithelial cells and fibroblasts, either alone or with the
CFTR. In each cell type, co-expression of CFTR caused
a small, but significant, reduction in sodium transport.
Moreover, sodium currents were reduced when the
CFTR was stimulated by cyclic AMP (CAMP) in the
absence of chloride ions. Because previous studies found
that sodium channels in cystic fibrosis tissues spent more
time in an open state, the combined results show that the
activated CFTR inhibits sodium channels by a chloride-
independent mechanism.
CFTR and outwardly rectifying chloride channels
A related issue is the role of an infamous chloride chan-
nel that allows chloride ions to enter the cell more easily
than they exit (a property called outward rectification).
Because this channel is commonly observed when
patches are excised and depolarized, it is referred to as an
'ORDIC' (outwardly rectifying depolarization-induced
chloride) channel, to distinguish it from other outwardly
rectifying chloride channels. The ORDIC channel is
defectively regulated by cAMP-regulated protein kinase
(PKA) in cystic fibrosis cells, and was considered by many
to be the 'cystic fibrosis channel', although this was con-
troversial even before the cystic fibrosis gene was cloned.
The controversy arose because the ORDIC channels
occur in most cell types examined, unlike the chloride
conductance that is defective in cystic fibrosis, which has
a restricted distribution. Also, the properties of the
ORDIC channels - notably stilbene inhibition and a
preference for iodide over chloride - are inconsistent
with their mediating the chloride conductance that is
missing in cystic fibrosis [9]. In patch-clamp studies of
single-channel activity, the ORDIC channel is rarely
observed in cell-attached patches, so most studies of this
channel have employed excised patches. In such excised
patches, however, activation by phosphorylation is erratic
and often takes many minutes to work. During this long
delay, the channel can activate spontaneously and irre-
versibly. When whole-cell recordings were used to avoid
the problems of excised patches, elevation of cAMP lev-
els induced non-rectifying currents! As a result of these
confusing findings, most researchers dropped their studies
of ORDIC channels with relief when it was demon-
strated that CFTR is an intrinsic chloride channel with
properties that fit both cAMP-mediated whole-cell
currents and the chloride conductance that is missing in
cystic fibrosis cells.
To his credit, William Guggino and his colleagues per-
sisted in trying to reconcile the new data on CFTR
channels and the older experiments with ORDIC chan-
nels, and in paper [10] they provide fascinating evidence
to support a model of indirect activation of ORDIC
channels. According to the model, when PKA and ATP
are applied to excised patches, they activate CFTR chan-
nels. CFTR then conducts ATP across the cell mem-
brane, where it activates purinergic receptors. The
purinergic receptors then activate ORDIC channels,
either directly or indirectly [10]. The model certainly
explains why experiments with ORDIC channels are not
easy to reproduce. If this model is correct, to observe
ORDIC channels in a patch-clamp study, a patch must
have a functional CFTR channel, an ORDIC channel, a
purinergic receptor and perhaps associated G proteins
(GTP-binding proteins that transduce signals from
certain types of receptor).
Several lines of evidence support this model [10]. In nor-
mal cells, but not in cystic fibrosis cells, whole-cell cur-
rents activated by cAMP develop an outwardly rectifying
component when the ATP in the pipet is increased above
2.5 mM, and in excised patches outwardly rectifying
channels can be seen. Strikingly, the whole-cell and
single-channel currents are blocked by extracellular scav-
engers of ATP. Also, with 500 nM ATP in bath and
pipet, active ORDIC channels were observed right after
patches were made, in either cystic fibrosis or normal
cells (the channel activity decreased by 90 % within three
minutes; the reason for this lability is not known, but it
may also contribute to the variable results). Finally, ATP
currents can reportedly be measured through CFTR
[10,11], although this is also disputed. These results go a
long way toward resolving old controversies, and should
generate research to test the model further and to deter-
mine if a similar mechanism is responsible for the nega-
tive regulation of sodium channels by CFTR.
What is the clinical significance of these results?
Is the regulation of other channels by CFTR more or less
important than its intrinsic chloride conductance? This
question is of vital interest to the cystic fibrosis commu-
nity, for if loss of the purinergic pathway is an important
component of disease, then supplying purines exoge-
nously should ameliorate the disease. And if enhanced
sodium absorption is important, then blocking sodium
channels should ameliorate the disease. Both of these
predictions are now being tested clinically [12], but
because clinical trials are notoriously slow and rarely
unequivocal in their outcomes, we certainly need to look
to other kinds of evidence to provide guidance on these
questions.
Studies of cystic fibrosis 'knockout' mice, generated
by gene targeting, together with genotype/phenotype
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analysis of human cystic fibrosis subjects, have provided
some of the best evidence that it is the loss of CFTR-
mediated epithelial chloride conductance that is primar-
ily responsible for cystic fibrosis disease. Four kinds of
evidence are now available. First, the knockout mice,
which lack CFTR entirely, have profound intestinal dis-
ease that is fatal without intervention, but, unlike their
human counterparts, their lungs and pancreas are mini-
mally affected, and male mice are fertile [13]. The spar-
ing of mouse organs from cystic fibrosis disease correlates
with the expression of alternative chloride channels in
the mouse pancreas, lungs and sperm duct [14], suggest-
ing that chloride conductance per se can protect against
cystic fibrosis disease, presumably by allowing relatively
normal fluid and electrolyte transport in these organs.
Second, measurements of ion transport in intestinal biop-
sies from cystic fibrosis subjects having identical CFTR
mutations but varying clinical status shows a positive cor-
relation between the magnitude of an alternative chloride
conductance and mildness of the disease [15]. Third,
CFTR mutations that partially reduce chloride conduc-
tance through CFTR result in milder disease, especially
in the pancreas [16]. Finally, in three cell types that are
profoundly affected in cystic fibrosis, namely sweat duct
cells, intestinal crypt cells and lung serous cells, CFTR
channels appear to be the exclusive form of apical chlor-
ide channel. Taken together, these results indicate that
chloride conductance is what matters, and the organ
does not care if it is through CFTR or a different chlor-
ide channel. It is organs that rely exclusively on intrinsic
CFTR-mediated chloride conductance that are most
affected in cystic fibrosis.
Conclusion
A dozen years have passed since Paul Quinton [2] first
proposed that lost epithelial chloride conductance might
be the key defect in cystic fibrosis, and support for his
hypothesis has never been stronger. However, the evi-
dence that expression of CFTR has multiple conse-
quences for cell physiology is now unequivocal. How
CFTR influences other cell properties is not known, but
the suggestion that CFTR exports ATP that binds to
extracellular purinergic receptors is a precise, testable
hypothesis that has received considerable initial support.
This hypothesis deserves to be tested further, especially in
tissues and conditions that are most relevant to cystic
fibrosis disease.
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